2026 NPPES data Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician NPI 1437342847 MD
Verify on CMS →

GRACE LEVY-CLARKE, MD

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician in TAMPA, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
232
Medicare Part D claims · 64 beneficiaries · Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician avg: 642
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.1061/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$1.6K
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GRACE LEVY-CLARKE, MD reported a CMS MIPS final score of 94.1061/100 — above the 83.1 national average — and filed 232 Medicare Part D claims in 2023.

94.1061/100
MIPS score · +11 vs avg
232
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GRACE LEVY-CLARKE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GRACE LEVY-CLARKE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GRACE LEVY-CLARKE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/20/2007

NPI 1437342847

Primary specialty

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician

Rare

37 US NPIs in this specialty

Medicare Part D claims

232 64% vs specialty avg

2023 prescription claims

Specialty avg: 642

MIPS final score

94.1061/100 11.006100000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician compares to other specialties among Florida providers

Florida providers

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within Florida

1. Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician share within Florida

Medicare quality performance — MIPS

GRACE LEVY-CLARKE, MD's 2023 MIPS final score plotted against the Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
94.1061/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — 94.1061/100 vs national avg 83.1

0%100%National avg83%94.1%
MIPS final score (Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician) — 94.1061/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GRACE LEVY-CLARKE, MD appears in the CMS NPPES registry as a Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider holding MD credentials at 11809 N DALE MABRY HWY, TAMPA, FL, 33618, with a listed phone of (727) 317-5830. NPI 1437342847 was issued on 08/20/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LEVY-CLARKE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 232 prescription claims written by this provider, covering 64 Medicare beneficiaries and totaling roughly $11K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.1061/100 for the 2023 performance year (Quality 78.4655), compared with the national average of 83.1.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician is a narrow specialty nationwide, with 37 enrolled providers across 15 states and an average of 642 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11809 N DALE MABRY HWY
TAMPA, FL 33618

Provider Details

NPI 1437342847
Specialty Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 08/20/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.1061
Final Score
Avg: 83.1
78.4655
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GRACE LEVY-CLARKE, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.6K

Largest payer

ANI Pharmaceuticals, Inc.

Most common payment type

Honoraria

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to GRACE LEVY-CLARKE, MD. To verify GRACE LEVY-CLARKE, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

GRACE LEVY-CLARKE, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 232 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

232
Total Claims
$11K
Total Drug Cost
64
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
341
Total Day Supply
9,239
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$5K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
69.8 years
Avg HCC Risk Score
1.47
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GRACE LEVY-CLARKE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
47
Ketorolac Tromethamine
24
Methylprednisolone
18
Valacyclovir
Valacyclovir Hcl
15
Erythromycin
Erythromycin Base
12
Prednisolone Acetate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Overview

How GRACE LEVY-CLARKE, MD fits within the Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician landscape nationally.

37
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Providers in US
15
States with Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician
642
Avg Claims per Provider

GRACE LEVY-CLARKE, MD's 232 claims are below the specialty average of 642.

Nearby Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as LEVY-CLARKE.

Compare Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GRACE LEVY-CLARKE, MD's specialty?
GRACE LEVY-CLARKE, MD specializes in Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician and practices in TAMPA, Florida. Credentials: MD.
How much does GRACE LEVY-CLARKE, MD prescribe under Medicare Part D?
In 2023, GRACE LEVY-CLARKE, MD wrote 232 Medicare Part D claims totaling $11K in drug costs for 64 beneficiaries.
What is GRACE LEVY-CLARKE, MD's Medicare quality score?
GRACE LEVY-CLARKE, MD has a CMS MIPS Final Score of 94.1061/100 (Quality: 78.4655). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GRACE LEVY-CLARKE, MD located?
GRACE LEVY-CLARKE, MD is located at 11809 N DALE MABRY HWY, TAMPA, FL, 33618. Phone: (727) 317-5830.
What is GRACE LEVY-CLARKE, MD's NPI number?
GRACE LEVY-CLARKE, MD's National Provider Identifier (NPI) is 1437342847, issued on 08/20/2007.
Does GRACE LEVY-CLARKE, MD prescribe more brand-name or generic drugs?
GRACE LEVY-CLARKE, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $5K in brand drug costs.
How many Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers are there in the US?
There are 37 Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers across 15 states in the US. The average Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician provider writes 642 Medicare Part D claims per year.
What drugs does GRACE LEVY-CLARKE, MD prescribe most often?
Based on 2023 Medicare Part D data, GRACE LEVY-CLARKE, MD's most frequently prescribed drugs include Prednisone, Ketorolac Tromethamine, Methylprednisolone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GRACE LEVY-CLARKE, MD accept Medicare?
GRACE LEVY-CLARKE, MD appears in CMS Medicare data with 232 Part D claims and 64 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GRACE LEVY-CLARKE, MD's credentials?
GRACE LEVY-CLARKE, MD's NPI is 1437342847 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology